Sotera Health (NASDAQ:SHC) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Sotera Health (NASDAQ:SHCGet Free Report) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $15.92.

SHC has been the subject of several research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Finally, Barclays reduced their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday, February 28th.

Check Out Our Latest Analysis on Sotera Health

Hedge Funds Weigh In On Sotera Health

A number of large investors have recently bought and sold shares of the company. Darsana Capital Partners LP raised its position in Sotera Health by 716.9% during the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock worth $334,167,000 after buying an additional 17,560,636 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Sotera Health by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company’s stock worth $204,154,000 after purchasing an additional 173,341 shares during the period. Sessa Capital IM L.P. grew its stake in shares of Sotera Health by 46.5% during the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after purchasing an additional 2,000,000 shares during the period. Sculptor Capital LP acquired a new position in shares of Sotera Health during the 4th quarter worth $68,400,000. Finally, State Street Corp grew its stake in shares of Sotera Health by 18.5% during the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after purchasing an additional 644,236 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Up 0.5 %

Shares of NASDAQ:SHC opened at $11.99 on Wednesday. The company has a market capitalization of $3.40 billion, a PE ratio of 47.96 and a beta of 1.92. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.08. The firm has a 50 day simple moving average of $13.01 and a 200-day simple moving average of $14.21.

Sotera Health Company Profile

(Get Free Report

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Featured Articles

Analyst Recommendations for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.